XORTX Therapeutics (XRTX) - 2025 Q2 - Quarterly Report

XORTX THERAPEUTICS INC. Exhibit 99.1 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS As at and for the three and six months ended June 30, 2025 and 2024 (Unaudited - expressed in U.S. Dollars) Director Director /s/ "Allen Davidof " /s/ "Paul Van Damme" The accompanying notes are an integral part of these condensed interim consolidated financial statements. 2 XORTX THERAPEUTICS INC. Condensed Interim Consolidated Statements of Financial Position (Unaudited - expressed in U.S. Dollars) | | | | December | ...